Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma We assessed ...
We conducted a retrospective, country-level study integrating GLOBOCAN 2022 incidence and mortality data, ClinicalTrials.gov records (2004-2025), and socioeconomic indicators (United Nations ...
Ballad Health reduced all-cause mortality by 22% and lowered its observed-to-expected mortality ratio by 10% between fiscal years 2023 and 2025. This progress is more than an operational win. It ...